Flt3l

Flt3l, or Fms-like tyrosine kinase 3 ligand, is a crucial cytokine that plays a fundamental role in the development and regulation of hematopoietic and immune cells within the body.

Flt3l

Key Takeaways

  • Flt3l is a cytokine essential for the proliferation, differentiation, and survival of hematopoietic stem and progenitor cells.
  • It primarily functions by binding to the Flt3 receptor, initiating signaling pathways vital for cell development.
  • Flt3l is particularly important for the generation and maturation of various immune cells, notably dendritic cells.
  • Dysregulation of Flt3l signaling can have implications for immune system function and may contribute to certain hematological disorders.
  • The Flt3l gene provides the genetic blueprint for producing this important protein, influencing its availability and activity.

What is Flt3l (Fms-Like Tyrosine Kinase 3 Ligand)?

Flt3l, an abbreviation for Fms-like tyrosine kinase 3 ligand, refers to a naturally occurring cytokine that is indispensable for the normal functioning of the hematopoietic and immune systems. It is a soluble protein that acts as a growth factor, primarily stimulating the proliferation and differentiation of hematopoietic stem cells (HSCs) and progenitor cells. This ligand is a member of the Fms-like tyrosine kinase family and plays a pivotal role in the early stages of blood cell development.

The presence and activity of Flt3l are critical for maintaining a healthy supply of various blood cell types, including those involved in immune responses. Its discovery has significantly advanced our understanding of how the body regulates the production of its diverse cellular components, particularly within the bone marrow where hematopoiesis occurs.

Flt3l Protein Function and Biological Significance

The primary Flt3l protein definition and role centers on its ability to bind to and activate the Fms-like tyrosine kinase 3 (Flt3) receptor, which is expressed on the surface of hematopoietic stem and progenitor cells. This binding initiates a cascade of intracellular signaling events that promote cell survival, proliferation, and differentiation. Without adequate Flt3l, the development of these crucial precursor cells would be severely impaired, leading to deficiencies in mature blood cell populations.

The Flt3l biological significance is particularly pronounced in the development of the immune system, especially in the generation of dendritic cells (DCs). Dendritic cells are professional antigen-presenting cells that are crucial for initiating adaptive immune responses. Flt3l is considered the most potent cytokine for promoting the expansion and differentiation of DC precursors. Its influence extends to various stages of hematopoiesis, impacting the lineage commitment and maturation of several cell types. Key cellular processes influenced by Flt3l include:

  • Stimulation of hematopoietic stem cell proliferation.
  • Promotion of progenitor cell differentiation into various myeloid and lymphoid lineages.
  • Critical support for the development and expansion of dendritic cells.
  • Enhancement of cell survival pathways in target cells.

Dysregulation of Flt3l signaling can have profound effects on immune function and has been implicated in the pathogenesis of certain hematological malignancies, such as acute myeloid leukemia (AML), where mutations in the Flt3 receptor are common. Understanding its precise functions is therefore vital for developing targeted therapeutic strategies.

Flt3l Gene Information

The Flt3l gene information provides the blueprint for the synthesis of the Flt3l protein. In humans, the FLT3LG gene is located on chromosome 19 at position 19q13.3. This gene encodes a protein that, after synthesis, undergoes processing to become the active soluble cytokine. The expression of the FLT3LG gene is tightly regulated, ensuring that Flt3l is produced in appropriate amounts and at the correct times to support ongoing hematopoiesis and immune cell development.

Variations or mutations within the FLT3LG gene, though less commonly studied than mutations in its receptor (Flt3), could potentially alter the structure or function of the Flt3l protein, thereby affecting its ability to bind to the Flt3 receptor and initiate downstream signaling. Research into the genetic regulation of Flt3l continues to shed light on its complex role in health and disease, offering insights into potential diagnostic markers or therapeutic targets for conditions involving hematopoietic and immune system dysregulation.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.